BP Genomics, an innovative leader in detection assays, sample processing, and nucleic acid technologies has partnered with Opentrons, a unique and forward thinking liquid handling company, whose passion lies in democratizing the automated pipetting revolution. Collaborating together, they are now in the final stages of fully validating an end-to-end solution to collect, process and detect the coronavirus (2019_nCoV).